{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:18:45Z","timestamp":1789849125460,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1178482"],"award-info":[{"award-number":["1178482"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejogrb.2023.06.028","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T03:02:38Z","timestamp":1687921358000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5742-9148","authenticated-orcid":false,"given":"Samantha S.","family":"Mooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Sumithran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2023.06.028_b0005","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. IARC; 2014; Lyon."},{"issue":"9612","key":"10.1016\/j.ejogrb.2023.06.028_b0010","first-page":"569","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Tyson","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0015","unstructured":"Gallos ID, Alazzam M, Clark TJ, et al. Management of endometrial hyperplasia. RCOG\/BSGE Green-top Guideline No. 67 [Available from: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/green-top-guidelines\/gtg_67_endometrial_hyperplasia.pdf."},{"key":"10.1016\/j.ejogrb.2023.06.028_b0020","doi-asserted-by":"crossref","unstructured":"Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S, et al. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort\\mathord{-} a factor analysis. Am J Epidemiol. 2013;177(8):787-99.","DOI":"10.1093\/aje\/kws309"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.06.028_b0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/1471-0528.12100","article-title":"Bariatric surgery an endometrial pathology in asymptomatic morbidly obese women: a prospective pilot study","volume":"120","author":"Argenta","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0030","unstructured":"Gallos ID, Alazza M, Clark TJ, Faraj R, Rosenthal AN, Smith PP, et al. Management of Endometrial Hyperplasia. RCOG\/BSGE Green-top Guideline No. 67 2016 [Available from: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/green-top-guidelines\/gtg_67_endometrial_hyperplasia.pdf."},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.028_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AOG.0b013e3181e93330","article-title":"Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy","volume":"116","author":"Reed","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.06.028_b0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.rbmo.2021.08.022","article-title":"Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia","volume":"43","author":"Campo","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.028_b0045","article-title":"Interventions for weight reduction in obesity to improve survival in women with endometrial cancer","volume":"2","author":"Kitson","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.06.028_b0050","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/ijgc-2019-000728","article-title":"Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysis","volume":"29","author":"Zhang","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.028_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2013.11.012","article-title":"Bariatric surgery decreases the risk of uterine malignancy","volume":"133","author":"Ward","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.06.028_b0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","article-title":"Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial","volume":"10","author":"Sj\u00f6str\u00f6m","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.06.028_b0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/oby.2008.610","article-title":"Cancer incidence and mortality after gastric bypass surgery","volume":"17","author":"Adams","year":"2009","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.028_b0070","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clbc.2012.12.002","article-title":"Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese","volume":"13","author":"Rock","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0075","unstructured":"Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000."},{"key":"10.1016\/j.ejogrb.2023.06.028_b0080","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed). 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.028_b0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2015.05.015","article-title":"Women at extreme risk for obesity-related carcinogenesis: Baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life","volume":"138","author":"Modesitt","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.028_b0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.31913","article-title":"The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk","volume":"144","author":"MacKintosh","year":"2019","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.06.028_b0095","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.soard.2014.03.023","article-title":"Bariatric surgery-induced weight loss changes immune markers in the endometrium of morbidly obese women","volume":"10","author":"Linkov","year":"2014","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.028_b0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2013.12.005","article-title":"Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery","volume":"133","author":"Argenta","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.06.028_b0105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.21614\/chirurgia.114.6.704","article-title":"The effect of bariatric surgery on premalignant endometrial pathology in morbidly obese patients","volume":"114","author":"Balescu","year":"2019","journal-title":"Chirurgia (Bucur)"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.028_b0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0034-1396256","article-title":"New WHO classification of endometrial hyperplasias","volume":"75","author":"Emons","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.06.028_b0115","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer-viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.028_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-013-2730-8","article-title":"Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10% weight loss in postmenopausal women","volume":"142","author":"Fabian","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.06.028_b0125","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s11695-018-3151-x","article-title":"Does bariatric surgery affect the incidence of endometrial cancer development? A systematic review","volume":"28","author":"Winder","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejogrb.2018.02.017","article-title":"The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications","volume":"223","author":"Parsons","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.06.028_b0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/1471-0528.12106","article-title":"Obesity-driven endometrial cancer: is weight loss the answer?","volume":"120","author":"Mackintosh","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ije\/dyi226","article-title":"Weight change and risk of endometrial cancer","volume":"35","author":"Trentham-Dietz","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.06.028_b0145","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","article-title":"Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity","volume":"23","author":"Magkos","year":"2016","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.06.028_b0150","first-page":"1789","article-title":"392-classification and management of endometrial hyperplasia","volume":"41","author":"Auclair","year":"2019","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0155","doi-asserted-by":"crossref","unstructured":"The American College of Obstetricians and Gynecologists Committee Opinion no. 6 Endometrial intraepithelial neoplasia. Obstet Gynecol. 2015;125(5):1272-8.","DOI":"10.1097\/01.AOG.0000465189.50026.20"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.06.028_b0160","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s12325-021-01693-y","article-title":"Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer: a cochrane systematic review protocol","volume":"38","author":"Fernandez-Montoli","year":"2021","journal-title":"Adv Ther"},{"issue":"20","key":"10.1016\/j.ejogrb.2023.06.028_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205024","article-title":"Effects of weight status and related metabolic disorders on fertility-sparing treatment outcomes in endometrial atypical hyperplasia and endometrial cancer: a retrospective study","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.06.028_b0170","article-title":"Cyclical progestogens for heavy menstrual bleeding","volume":"8","author":"Bofill Rodriguez","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"10.1016\/j.ejogrb.2023.06.028_b0175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jpag.2021.08.004","article-title":"Does obesity influence body mass index changes in nulliparous adolescent users of long-acting reversible contraceptives?","volume":"34","author":"Scott","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100800","article-title":"Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: findings from a randomised, multicentre, open-label trial","volume":"34","author":"Beksinska","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0185","doi-asserted-by":"crossref","unstructured":"Barr CE, Ryan NAJ, Derbyshire AE, Wan YL, MacKintosh ML, McVey RJ, et al. Weight loss during intrauterine progestin treatment for obesity-associated atypical hyperplasia and early-stage cancer of the endometrium. Cancer Prev Res (Philadelphia, Pa). 2021;14(11):1041-50.","DOI":"10.1158\/1940-6207.CAPR-21-0229"},{"key":"10.1016\/j.ejogrb.2023.06.028_b0190","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.2147\/CMAR.S316040","article-title":"Weight loss improves pregnancy and livebirth outcomes in young women with early-stage endometrial cancer and atypical hyperplasia","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag Res"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523002701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523002701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:00:48Z","timestamp":1759557648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523002701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":38,"alternative-id":["S0301211523002701"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.06.028","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}